只使用免费官方源:SEC Forms 3/4/5 结构化内部人申报,以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界,不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量;个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S(公开市场或私下交易),成交金额由股数 × 每股价格计算。
官方数据说明| 2026-06-18 2026-06-22 | KHC Kraft Heinz Co | Frost Diana Officer · Glbl Chief Growth Officer | 卖出(S) | 18,502 | US$23.05 | US$426,471.10 | 102,667 | SEC |
| 2026-06-12 2026-06-15 | CFR CULLEN/FROST BANKERS, INC. | Severyn Carol Jean Officer · GEVP and Chief Risk Officer | 卖出(S) | 837 | US$148.29 | US$124,118.73 | 12,712 | SEC |
| 2026-06-01 2026-06-02 | FENC FENNEC PHARMACEUTICALS INC. | Raykov Rosty Director | 卖出(S) | 9,747 | US$9.62 | US$93,766.14 | 130,079 | SEC |
| 2026-05-19 2026-05-21 | PCTY Paylocity Holding Corp | Rost Nicholas Officer · VP CAO & Treasurer | 卖出(S) | 521 | US$115.05 | US$59,941.05 | 6,676 | SEC |
| 2026-05-01 2026-05-01 | FENC FENNEC PHARMACEUTICALS INC. | Raykov Rosty Director | 卖出(S) | 10,781 | US$6.47 | US$69,753.07 | 121,451 | SEC |
| 2026-04-01 2026-04-02 | FENC FENNEC PHARMACEUTICALS INC. | Raykov Rosty Director | 卖出(S) | 10,946 | US$6.31 | US$69,069.26 | 113,856 | SEC |
| 2026-03-16 2026-04-01 | HBIO HARVARD BIOSCIENCE INC | Frost Mark T Officer · Chief Financial Officer | 买入(P) | 5,000 | US$5.00 | US$25,000.00 | 17,500 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| ROST | 240,137.071 | 196 | 475,335.9932 | 50.52% | B, Q, N |